Patrick Schnell
About Patrick Schnell
Patrick Schnell is the Executive Medical Director at BeiGene with over 15 years of experience in drug safety and risk management.
Title
Patrick Schnell holds the title of Executive Medical Director at BeiGene since May 2021.
Current Role at BeiGene
Patrick Schnell joined BeiGene in May 2021 as the Executive Medical Director. With over 15 years of expertise in drug safety and risk management, he plays a key role in overseeing the medical and safety aspects of the company's clinical programs.
Experience at Pfizer
Patrick Schnell spent 13 years at Pfizer, holding multiple leadership roles. From 2019 to 2021, he served as Disease Area Cluster Lead in Greater New York City Area. Prior to that, he was the Senior Medical Director, Safety Risk Lead from 2010 to 2021 in New York, where he was involved in safety risk management and medical oversight.
Previous Role at Bayer HealthCare
Patrick Schnell worked at Bayer HealthCare for 4 years, from 2006 to 2010, as MD, Drug Safety. During his tenure, he was responsible for ensuring the safety of pharmaceutical products and managing risks associated with drug usage.
Educational Background in Medicine
Patrick Schnell has a strong educational background in medicine. He earned his medical degree from Georg-August-Universität Göttingen, studying from 1988 to 1992, and also attended Johannes Gutenberg-Universität Mainz from 1986 to 1988.